Table 1.
Treatment outcomes by regimen for patients without a history of previous VL treatment (based on data retrieved from patient records at community health centers)
| Outcome/ Regimen | SSG (95% CI) |
miltefosine (95% CI) |
amphotericin B (95% CI) |
All (95% CI) |
|---|---|---|---|---|
| Treatment success | 51 (75%) (64-86%) |
37 (86%) (75-97%) |
29 (94%) (84-100%) |
117 (82.4%) (76.1-88.7%) |
| Failure | 2 (3%) (0-7%) |
0 | 0 | 2 (1.4%) (0-3.4%) |
| Defaulted | 4 (6%) (0-12%) |
3 (7%) (0-15%) |
1 (3%) (0-10%) |
8 (5.6%) (1.8-9.5%) |
| Died | 1 (1%) (0-4%) |
1 (2%) (0-7%) |
0 | 2 (1.4%) (0-3.4%) |
| Referred | 8 (12%) (4-20%) |
2 (5%) (0-11%) |
1 (3%) (0-10%) |
11 (7.7%) (3.3 -12.2%) |
| Transferred out | 2 (3%) (0-7%) |
0 | 0 | 2 (1.4%) (0-3.4%) |
| Total | 68 | 43 | 31 | 142 |